Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CYSTIC FIBROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06663176
What this trial is testing

Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa)

Who this might be right for
Non-Cystic Fibrosis Bronchiectasis
Thirty Respiratory Limited 60
Not applicableStudy completedNCT00164138
What this trial is testing

Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease

Who this might be right for
Cystic FibrosisChronic Obstructive Pulmonary Disease (COPD)
Bayside Health 99
Not applicableUnknownNCT05561868
What this trial is testing

COVID-19 Antibody Responses in Cystic Fibrosis

Who this might be right for
Cystic FibrosisCOVID-19
Children's Health Ireland 70
Testing effectiveness (Phase 2)Ended earlyNCT02759562
What this trial is testing

Effect of Andecaliximab on FEV1 in Adults With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Gilead Sciences 6
Not applicableUnknownNCT03264950
What this trial is testing

Utility of Point Shear-wave Elastography to Assess for Hepatic & Pancreatic Fibrosis in Pediatric CF Patients

Who this might be right for
Cystic FibrosisCystic Fibrosis Liver DiseasePancreatic Insufficiency Due to Cystic Fibrosis of Pancreas
University of Manitoba 60
Testing effectiveness (Phase 2)Study completedNCT00006280
What this trial is testing

The Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 98
Testing effectiveness (Phase 2)Ended earlyNCT02955888
What this trial is testing

Study of Safety, Tolerability & Efficacy in Cystic Fibrosis Patients With Abnormal Glucose Tolerance

Who this might be right for
Cystic Fibrosis
Liminal BioSciences Ltd. 11
Not applicableStudy completedNCT02832479
What this trial is testing

Costs of Care and Adherence to Treatment for Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Hospices Civils de Lyon 500
Not applicableStudy completedNCT01860872
What this trial is testing

Comparing Chest Images From MRI to CT in Patients With Cystic Fibrosis (CF)

Who this might be right for
Cystic Fibrosis
Children's Hospital Medical Center, Cincinnati 64
Large-scale testing (Phase 3)Study completedNCT01117012
What this trial is testing

Rollover Study of VX-770 in Cystic Fibrosis Subjects

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 192
Not applicableStudy completedNCT02194881
What this trial is testing

Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation

Who this might be right for
Cystic Fibrosis
Assistance Publique - Hôpitaux de Paris 57
Not applicableEnded earlyNCT01586728
What this trial is testing

Oxygen Therapy in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Assistance Publique - Hôpitaux de Paris 8
Not applicableStudy completedNCT06072365
What this trial is testing

Treatment With Elexacaftor/Tezacaftor/Ivacaftor, in Patients With Cystic Fibrosis and Caloric Intake

Who this might be right for
Cystic Fibrosis
University Hospital, Toulouse 120
Large-scale testing (Phase 3)Study completedNCT02412111
What this trial is testing

Tezacaftor (VX-661) in Combination With Ivacaftor (VX-770) in Subjects Aged 12 Years and Older With Cystic Fibrosis (CF), Who Have One F508del-CFTR Mutation and a Second Mutation That Has Been Demonstrated to be Clinically Responsive to Ivacaftor

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 156
Not applicableEnded earlyNCT01329172
What this trial is testing

Nasal Mucin Oral Supplementation Treatment Respiratory Inflammation Using PUFA in Cystic Fibrosis (CF) Patients

Who this might be right for
Cystic FibrosisDietary Modification
University Hospital, Lille 7
Not applicableActive Not RecruitingNCT04206436
What this trial is testing

CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis

Who this might be right for
Cystic FibrosisBone LossMuscle Loss
Indiana University 63
Not applicableUnknownNCT02850692
What this trial is testing

Portal Hypertension and Systemic Endothelial Function

Who this might be right for
Cystic FibrosisPortal Hypertension
Hopital Foch 60
Not applicableStudy completedNCT00333957
What this trial is testing

Capsule Endoscopy in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Hadassah Medical Organization 200
Not applicableStudy completedNCT00362739
What this trial is testing

Blood Collection From Individuals With Lung Disease for Genetic Studies

Who this might be right for
AsthmaCOPDInterstitial Lung Disease+2 more
Weill Medical College of Cornell University 3,087
Not applicableUnknownNCT01288170
What this trial is testing

Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus®

Who this might be right for
Cystic Fibrosis
Erempharma 12
Next Page